Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q4 EPS of ($0.27), $0.11 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.